These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 3986248)
1. [Structure of the binding center of the serotonin S2 receptor]. Kats MM Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (3):19-24. PubMed ID: 3986248 [TBL] [Abstract][Full Text] [Related]
2. Theoretical models of interactions between buspirone analogues and 5-HT1A and 5-HT2A serotonin receptor subtypes. Bronowska A; Sylte I; Edvardsen Ø; Østensen R; Leś A; Chilmonczyk Z Acta Pol Pharm; 2000 Nov; 57 Suppl():40-5. PubMed ID: 11293260 [TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics of the 5-HT1a receptor and ligands. Sylte I; Edvardsen O; Dahl SG Protein Eng; 1993 Sep; 6(7):691-700. PubMed ID: 8248092 [TBL] [Abstract][Full Text] [Related]
4. A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites. Kuipers W; Van Wijngaarden I; Ijzerman AP Drug Des Discov; 1994 Apr; 11(3):231-49. PubMed ID: 7548638 [TBL] [Abstract][Full Text] [Related]
5. Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models. Gaillard P; Carrupt PA; Testa B; Schambel P J Med Chem; 1996 Jan; 39(1):126-34. PubMed ID: 8568799 [TBL] [Abstract][Full Text] [Related]
6. Correlation of inhibitory activity of tryptamine derivatives on serotonin uptake in thrombocyte with van der Waals volume. Gupta SP; Singh P; Bindal MC Arzneimittelforschung; 1981; 31(12):2053-5. PubMed ID: 7199296 [TBL] [Abstract][Full Text] [Related]
7. Quantum chemical approach to the relationship between molecular structure and serotonin receptor binding affinity. Gómez-Jeria JS; Morales-Lagos DR J Pharm Sci; 1984 Dec; 73(12):1725-8. PubMed ID: 6527244 [TBL] [Abstract][Full Text] [Related]
8. Towards the development of 5-HT₇ ligands combining serotonin-like and arylpiperazine moieties. Spadoni G; Bedini A; Bartolucci S; Pala D; Mor M; Riccioni T; Borsini F; Cabri W; Celona D; Marzi M; Tarzia G; Rivara S; Minetti P Eur J Med Chem; 2014 Jun; 80():8-35. PubMed ID: 24763360 [TBL] [Abstract][Full Text] [Related]
9. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus. Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116 [TBL] [Abstract][Full Text] [Related]
10. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors. Cappelli A; Anzini M; Vomero S; Canullo L; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Bruni G; Romeo MR; Giorgi G; Donati A J Med Chem; 1999 May; 42(9):1556-75. PubMed ID: 10229626 [TBL] [Abstract][Full Text] [Related]
11. Molecular electrostatic potentials: a critical assessment in QSAR and a tryptamine binding model. Hadzi D; Koller J; Hodoscek M Prog Clin Biol Res; 1989; 291():259-63. PubMed ID: 2726857 [No Abstract] [Full Text] [Related]
13. Binding of tryptamine analogs at h5-HT1E receptors: a structure-affinity investigation. Dukat M; Smith C; Herrick-Davis K; Teitler M; Glennon RA Bioorg Med Chem; 2004 May; 12(10):2545-52. PubMed ID: 15110837 [TBL] [Abstract][Full Text] [Related]